Adaptive Biotechnologies

United States
Seattle, United States, Washington
(206) 659-0067 ★

Company profile

Adaptive Biotechnologies company profile

Adaptive Biotechnologies is a publicly traded biotechnology company that applies immune receptor sequencing and computational biology to develop diagnostic, therapeutic, and drug discovery tools centered on the adaptive immune system.

Business identity

Contact email
[email protected]
Phone number
(206) 659-0067
Operating status
Active
Company type
For Profit
Employee range
00501-01000 employees
Revenue range
$100K+
Founded
2009-01-01

Headquarters

Headquarters
Seattle, United States, Washington
Postal code
98102
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
11
Total equity funding
$404.4M
Last funding
Post Ipo Debt / $125M / 2022-09-12
Last equity funding
Post Ipo Equity
Investors
9
Lead investors
4
Founders
3
Articles
360
Exited on
2019-06-26

Founders and investors

Founders

Chad RobinsChristopher CarlsonHarlan Robins

Lead investors

ARK Investment ManagementMatrix Capital ManagementOrbiMedViking Global Investors

Investors

ARK Investment ManagementOrbiMedRock Springs CapitalSenator Investment GroupViking Global Investors

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.